MedTrace Logo

Safety and Effectiveness of JUVÉDERM® VOLBELLA® With Lidocaine for Lip Enhancement in Chinese Adults

NCT03519204 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2019-08-06

Study results available
· View outcomes & findings →

Summary

This study will evaluate the safety and effectiveness of VOLBELLA with Lidocaine injectable gel in Chinese adults seeking lip enhancement.

Conditions

  • Lip Enhancement

Interventions

DEVICE

JUVÉDERM® VOLBELLA® XC with Lidocaine

JUVÉDERM® VOLBELLA® XC with lidocaine injected into lips.

OTHER

No-treatment Control

No-treatment was administered.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Smita Chawla · Allergan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-28
Primary Completion
2018-03-30
Completion
2018-03-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03519204 on ClinicalTrials.gov